Cargando…
Convalescent plasma may not be an effective treatment for severe and critically ill covid-19 patients: A Systematic Review & Meta-Analysis of Randomized Controlled Trials
BACKGROUND: Convalescent plasma treatment for severe and critically ill Corona Virus Disease 2019 (COVID-19) patients remains controversial. OBJECTIVE: To evaluate the clinical improvement and mortality risk of convalescent plasma treatment in patients with severe and critically ill COVID-19 patient...
Autores principales: | Yang, Penglei, Wang, Jing, Zheng, Ruiqiang, Tan, Rui, Li, Xianghui, Liu, Xiaoyun, Li, Yang, Yuan, Zhenzhen, Wang, Yue, Chen, Qihong, Yu, Jiangquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806131/ https://www.ncbi.nlm.nih.gov/pubmed/35149308 http://dx.doi.org/10.1016/j.hrtlng.2022.01.019 |
Ejemplares similares
-
Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key
por: Yu, Jiangquan, et al.
Publicado: (2021) -
Construction of a predictive model and prognosis of left ventricular systolic dysfunction in patients with sepsis based on the diagnosis using left ventricular global longitudinal strain
por: Yu, Jiangquan, et al.
Publicado: (2022) -
Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Zhang, Bin, et al.
Publicado: (2020) -
What's new in critical illness and injury science? Convalescent plasma for coronavirus disease-2019 patients with severe or critical illness
por: Miller, Andrew Carl, et al.
Publicado: (2021) -
Rethinking the role of COVID-19 convalescent plasma in the critically ill
por: Casadevall, Arturo, et al.
Publicado: (2023)